MUNICH, Germany—In patients with stable coronary artery disease (CAD) and at least 1 proven ischemic stenosis, percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) plus ...

Forbes contributors publish independent expert analyses and insights. I'm a medical journalist covering cardiology news. Aug 28, 2012, 02:01am EDT Aug 28, 2012, 05:54am EDT This article is more than ...

(UPDATED) Individuals who leave the hospital against medical advice following PCI are more likely to be readmitted within 30 days than patients discharged home by physicians, and the most common ...

In a new study, researchers found discharge against medical advice as the strongest predictor of 30-day unplanned readmissions in heart attack patients. While only a small number of patients choose to ...

DENVER, CO — PCI guided by fractional flow reserve (FFR) measurement plus medical therapy improved long-term outcomes for a majority of patients with stable coronary artery disease compared with ...

People with a buildup of fatty atherosclerotic plaque in the heart's arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent percutaneous ...

Patients with stable coronary artery disease (CAD) today do no better with stents than with medical therapy, according to a new meta-analysis published in the Archives of Internal Medicine. Kathleen ...

Please provide your email address to receive an email when new articles are posted on . For patients with vulnerable plaque but no flow-limiting stenosis, PCI provided better clinical outcomes than ...

(HealthDay)—For patients with stable ischemic heart disease (SIHD) and objective evidence of ischemia, percutaneous coronary intervention (PCI) is associated with lower mortality than medical therapy ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — In the first randomized clinical trial to compare optimal medical therapy alone with PCI in ...

PCI has an established place in treating angina but is not superior to intensive medical therapy to prevent myocardial infarction and death. "The COURAGE trial should lead to changes in the treatment ...